Trial Profile
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia: an Observational, Non-interventional Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Europe
- 05 Apr 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last Verified April 2019 by Otsuka Pharmaceutical Europe Ltd).
- 09 Apr 2019 Planned End Date changed from 1 Nov 2018 to 31 Jan 2020.
- 09 Apr 2019 Planned primary completion date changed from 1 Nov 2018 to 31 Jan 2020.